Moors & Cabot, Inc. Axsome Therapeutics, Inc. Transaction History
Moors & Cabot, Inc.
- $2.02 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
332Shares Held
38.3MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$443 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$423 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$349 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$250 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$111 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.53B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...